XML 41 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Payments - 2017 Share Incentive Plan (Details) - 2017 Share Incentive Plan
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Jul. 26, 2017
shares
Mar. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2019
USD ($)
Dec. 31, 2018
item
Options        
Outstanding at beginning of year (in shares)   4,422,664    
Granted (in shares)   1,290,500    
Forfeited (in shares)   (138,520)    
Outstanding at end of year (in shares)   5,574,644    
Vested and exercisable at end of year (in shares)   1,820,897    
Weighted average exercise price in $ per share        
Outstanding balance at beginning of year (in dollars per share) | $ / shares   $ 3.55    
Granted (in dollars per share) | $ / shares   1.35    
Forfeited (in dollars per share) | $ / shares   3.07    
Outstanding balance at end of year (in dollars per share) | $ / shares   3.05    
Vested and exercisable balance at end of year (in dollars per share) | $ / shares   $ 4.32    
Fair Value Assumptions        
Weighted-average remaining contractual life   8 years 10 months 24 days    
Stock Options        
Share-Based Payments        
Vesting period   10 years    
Fair Value Assumptions        
Expected term of options (in years)   6 years 1 month 6 days    
Stock-Based Compensation Expense        
Share-based compensation expense | $   $ 0.6 $ 0.5  
Weighted-average grant date fair value (in dollars per share) | $ / shares   $ 0.80    
Unrecognized compensation expense        
Total unrecognized compensation related to unvested options | $   $ 5.1    
Recognition period   1 year 2 months 12 days    
Stock Options | Minimum        
Fair Value Assumptions        
Expected volatility (as a percent)   63.80%    
Risk-free interest rate (as a percent)   0.80%    
Term of U.S. treasury securities used to estimate risk free interest rate   5 years    
Stock Options | Maximum        
Fair Value Assumptions        
Expected volatility (as a percent)   64.00%    
Risk-free interest rate (as a percent)   1.50%    
Term of U.S. treasury securities used to estimate risk free interest rate   7 years    
SARs        
Share-Based Payments        
Vesting period   10 years    
Restricted Stock Units ("RSUs")        
Share-Based Payments        
Vesting period   4 years    
Fair Value | $   $ 0.3    
Stock-Based Compensation Expense        
Share-based compensation expense | $   0.6 $ 0.3  
Unrecognized compensation expense        
Unrecognized compensation costs | $   $ 3.2    
Recognition period   1 year 3 months 18 days    
Restricted Stock Units        
Weighted average grant date fair value per share | $ / shares   $ 1.35    
Number of shares outstanding   901,686    
Granted   1,557,300    
Vested and issued   (139,705)    
Forfeited   (32,260)    
Number of shares outstanding   2,287,021    
weighted average fair value per share        
Weighted average fair value at the beginning | $ / shares   $ 3.69    
Granted | $ / shares   1.35    
Vested and issued | $ / shares   1.90    
Forfeited | $ / shares   2.63    
Weighted average fair value at the end | $ / shares   $ 3.31    
Restricted Stock Units ("RSUs") | Vesting period, year one        
Restricted Stock Units        
Percentage that vests during the period   25.00%    
Restricted Stock Units ("RSUs") | Employees        
Share-Based Payments        
Number of vesting periods | item       3
Vesting period   4 years   6 years
Restricted Stock Units        
Percentage that vests during the period   25.00%    
Ordinary Shares        
Share-Based Payments        
Number of shares authorized 3,000,000      
Additional shares authorized 3,438,990      
Shares available for grant   985,975    
Ordinary Shares | Minimum        
Share-Based Payments        
Annual increase, to be added on the first day of each fiscal year (in shares) 2,000,000      
Annual increase, to be added on the first day of each fiscal year (as a percent) 4.00%      
XENLETA | Restricted Stock Units ("RSUs") | Immediate vesting upon regulatory approval        
Restricted Stock Units        
Percentage that vests during the period       50.00%
XENLETA | Restricted Stock Units ("RSUs") | Vesting upon the one-year-anniversary of FDA approval        
Restricted Stock Units        
Percentage that vests during the period       50.00%
CONTEPO | Restricted Stock Units ("RSUs") | Immediate vesting upon regulatory approval        
Restricted Stock Units        
Percentage that vests during the period       50.00%
CONTEPO | Restricted Stock Units ("RSUs") | Vesting upon the one-year-anniversary of FDA approval        
Restricted Stock Units        
Percentage that vests during the period       50.00%